LOGIXX RENEWS PARTNERSHIP WITH TOBY TRICE RACING

LogixX Pharma has renewed its partnership with Toby Trice Racing for 2022, as he embarks on his maiden season in the Porsche Visit Cayman Islands Sprint Challenge GB championship.

The pharmaceutical company joined forces with Toby last season, forging a great partnership which enabled growth for both parties, and off the back of a very successful first campaign, LogixX has made the decision to renew its partnership with the Kent based racing driver for another year.

“LogixX Pharma is absolutely thrilled to be supporting Toby Trice this year as he embarks on a new challenge as a new dad, but also stepping up a gear in motor racing in the Porsche Cayman Sprint Challenge,” explained LogixX Pharma’s CEO Michael Close.

LogixX Pharma has renewed its partnership with Toby Trice Racing for 2022, as he embarks on his maiden season in the Porsche Visit Cayman Islands Sprint Challenge GB championship.

The pharmaceutical company joined forces with Toby last season, forging a great partnership which enabled growth for both parties, and off the back of a very successful first campaign, LogixX has made the decision to renew its partnership with the Kent based racing driver for another year.

“LogixX Pharma is absolutely thrilled to be supporting Toby Trice this year as he embarks on a new challenge as a new dad, but also stepping up a gear in motor racing in the Porsche Cayman Sprint Challenge,” explained LogixX Pharma’s CEO Michael Close.

“It’s brilliant to have LogixX back onboard for 2022 as we continue our campaign racing for fertility,” said Toby.

“LogixX are doing so much for the benefit of couples going through fertility with research to improve testing and diagnostics, which ultimately will allow more couples to understand their own fertility.

“Really exciting times are ahead as we embark on season three of racing for fertility.”